Building capacity in countries to conduct thorough surveillance of the use of all newly authorized drugs and vaccines, both brand name and generic, is a critical “public good” investment to ensure that drugs work correctly and that their health benefits outweigh their known risks. Korea’s pharmacovigilance system (PVS) is an international best practice. It is the result of a continuous and sustained government effort over the past three decades—from...
Voir la suite
INFORMATION
-
2023/08/10
-
Rapport
-
184491
-
1
-
2023/08/10
-
Disclosed
-
Learning from Best Practices : An Overview of the Republic of Korea Pharmacovigilance System